R64Q (p.Arg64Gln) variant of SOST (Sclerostin)

R64Q (p.Arg64Gln) in SOST (Sclerostin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes population frequency data and structural context.

R64Q (p.Arg64Gln) variant details